However, an unchanged expression of Sirt1 suggests that PCB 126 promoted the development of NASH, at least in part, through mechanisms involving reduced fatty acid oxidation in the liver owing to reduced PPARα expression, possibly induced by miR-34a upregulation. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.